{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:35:10Z","timestamp":1782995710019,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.diagmicrobio.2010.10.013","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T15:14:39Z","timestamp":1300288479000},"page":"357-362","source":"Crossref","is-referenced-by-count":141,"title":["Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections"],"prefix":"10.1016","volume":"69","author":[{"given":"Elizabeth A.","family":"Neuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerri S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Endimiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabin K.","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"van Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0005","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum beta-lactamase\u2013producing Enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/605922","article-title":"Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"30","author":"Borer","year":"2009","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0015","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents","volume":"56","author":"Bratu","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.01114-07","article-title":"Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase\u2013producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program","volume":"52","author":"Castanheira","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0045","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement. 2009; CLSI document M100-S19."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2007.09.017","article-title":"Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase\u2013producing Klebsiella pneumoniae epidemic clone","volume":"60","author":"Cobo","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1086\/600042","article-title":"Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature","volume":"49","author":"Elemam","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/dkn547","article-title":"Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA","volume":"63","author":"Endimiani","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","article-title":"Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1086\/648720","article-title":"Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials","volume":"50","author":"Gardiner","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0075","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/648451","article-title":"Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"30","author":"Gasink","year":"2009","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkn555","article-title":"A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline","volume":"63","author":"Gordon","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0085","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1469-0691.2001.00204.x","article-title":"Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase\u2013producing strains of Pseudomonas and Acinetobacter species","volume":"7","author":"Lee","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajic.2007.10.013","article-title":"Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan","volume":"37","author":"Nadkarni","year":"2009","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","article-title":"Colistin in the 21st century","volume":"22","author":"Nation","year":"2009","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1086\/592412","article-title":"Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies","volume":"29","author":"Patel","year":"2008","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkl441","article-title":"Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report","volume":"59","author":"Peleg","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2009.02.009","article-title":"Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens","volume":"58","author":"Poulakou","year":"2009","journal-title":"J. Infect."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0125","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant Enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/649865","article-title":"An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes","volume":"50","author":"Souli","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0135","unstructured":"Tigecycline package insert. Wyeth Pharmaceuticals, Madison, NJ. Available at: http:\/\/www.wyeth.com\/content\/showlabeling.asp?id=491. Accessed February 24, 2010."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0140","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1128\/AAC.01768-09","article-title":"In vitro double and triple bactericidal activities of doripenem, polymyxin B and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli","volume":"54","author":"Urban","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.10.013_bb0145","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889310004542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889310004542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T19:26:27Z","timestamp":1543865187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889310004542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0732889310004542"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.10.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10652958.11531056","asserted-by":"object"}]},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}